Essential Psychopharmacology at a GlanceAn Update on New Medications for the Treatment of Major Depressive Disorder
Antipsychotic Polypharmacy in Psychosis
Pharmacological Enhancement of Cognition in Schizophrenia
Adjunctive Pharmacological Agents in the Treatment of Schizophrenia
Multiple Choice Questions: 4 per lesson
CME/CE Credits: 10
Approvals: NBCC, APA, ACCME, NAADAC
PLEASE NOTE: Program participants who took Directions in Psychiatry Volume 34 are NOT eligible to take this program.
CME/CE Lessons in Volume 3
American Medical Association
The Hatherleigh Company, Ltd. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Hatherleigh Company, Ltd. designates this CME activity for a maximum number of 10 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Hatherleigh Company, Ltd. is approved by the American Psychological Association to sponsor continuing education for psychologists. Hatherleigh maintains responsibility for the program and its' content.
The Hatherleigh Company, Ltd. is an NBCC-Approved Continuing Education Provider (ACEPTM) and may offer NBCC-approved clock hours for programs that meet NBCC requirements. Programs for which NBCC-approved clock hours will be awarded are identified on the Website. The ACEP is solely responsible for all aspects of the program. Our NBCC provider number is #5448.
The Hatherleigh Company, Ltd., is approved by The Association of Addiction Professionals. Our NAADAC provider number is #62695.
The American Nurses Credential Center’s Commission on Accreditation (ANCC) accepts CE programs by an APA approved provider. Please refer to the following information from the ANCC website at: http://www.nursecredentialing.org/RenewalRequirements.aspx